Note 9 - Capital Stock and Reserves (Details Textual)
|
|
|
|
1 Months Ended |
3 Months Ended |
12 Months Ended |
36 Months Ended |
|
|
|
Nov. 15, 2025 |
Apr. 01, 2025 |
Aug. 22, 2023
CAD ($)
$ / shares
shares
|
Aug. 22, 2023
USD ($)
$ / shares
shares
|
Mar. 31, 2024
CAD ($)
$ / shares
shares
|
Jun. 20, 2025
shares
|
Mar. 31, 2024
CAD ($)
$ / shares
shares
|
Mar. 31, 2025
CAD ($)
$ / shares
shares
|
Mar. 31, 2025
CAD ($)
$ / shares
$ / shares
shares
|
Mar. 31, 2024
CAD ($)
$ / shares
shares
|
Mar. 31, 2023
CAD ($)
$ / shares
shares
|
Mar. 31, 2022
CAD ($)
$ / shares
shares
|
Mar. 31, 2028 |
Mar. 31, 2025
CAD ($)
$ / shares
shares
|
Mar. 31, 2025
$ / shares
|
Aug. 24, 2023
CAD ($)
shares
|
Sep. 07, 2022
shares
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from exercise of warrants |
|
|
|
|
|
|
|
|
$ 0
|
|
|
|
$ 0
|
$ 1,059,017
|
|
|
|
|
|
|
|
Flow-through premium liability |
|
|
|
|
|
$ 11,666
|
|
$ 11,666
|
1,791,526
|
|
$ 1,791,526
|
|
11,666
|
0
|
$ 0
|
|
$ 1,791,526
|
|
|
|
|
Payments for share issue costs |
|
|
|
|
|
|
|
|
675,557
|
|
|
|
480,415
|
99,624
|
|
|
|
|
|
|
|
Proceeds from issuing shares |
|
|
|
|
|
|
|
|
11,850,379
|
|
|
|
7,047,668
|
1,661,807
|
|
|
|
|
|
|
|
Total equity |
|
|
|
|
|
$ 13,209,537
|
|
$ 13,209,537
|
$ 24,492,262
|
|
$ 24,492,262
|
|
$ 13,209,537
|
$ 10,387,622
|
$ 6,741,746
|
|
$ 24,492,262
|
|
|
|
|
Increase (decrease) in number of shares outstanding, issued for services (in shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
30,900
|
|
|
|
|
|
|
|
|
Issue of equity, shares issued for services |
|
|
|
|
|
|
|
|
|
|
|
|
$ 187,872
|
|
|
|
|
|
|
|
|
Number of share options exercised in share-based payment arrangement |
|
|
|
|
|
|
|
|
(0)
|
|
|
|
36,000
|
13,000
|
|
|
|
|
|
|
|
Proceeds from exercise of options |
|
|
|
|
|
|
|
|
$ 0
|
|
|
|
$ 131,400
|
$ 77,750
|
|
|
|
|
|
|
|
Increase (decrease) through exercise of options, equity |
|
|
|
|
|
|
|
|
|
|
|
|
131,400
|
$ 77,750
|
|
|
|
|
|
|
|
Increase in number of shares outstanding, exercise of warrants (in shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
212,750
|
|
|
|
|
|
|
|
Increase (decrease) through share-based payment transactions, equity |
|
|
|
|
|
|
|
|
$ 872,879
|
|
|
|
$ 910,700
|
$ 815,428
|
|
|
|
|
|
|
|
Number of share options expired in share-based payment arrangement |
|
|
|
|
|
|
|
|
156,589
|
|
|
|
80,300
|
|
|
|
|
|
|
|
|
Share-based arrangement, payment reserve, forfeited |
|
|
|
|
|
|
|
|
$ 619,093
|
|
|
|
|
$ 860,158
|
|
|
|
|
|
|
|
Reversal of share-based payments |
|
|
|
|
|
|
|
|
$ 134,962
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
339,542
|
|
|
|
238,500
|
121,000
|
|
|
|
|
|
|
|
Expense from share-based payment transactions |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 42,702
|
|
|
|
|
|
|
|
Stock options, repriced (in shares) | shares |
|
|
|
|
|
|
|
|
387,920
|
|
|
|
|
|
|
|
|
|
|
|
|
Incremental fair value granted, modified share-based payment arrangements |
|
|
|
|
|
|
|
|
$ 13,200
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options forfeited in share-based payment arrangement |
|
|
|
|
|
|
|
|
156,589
|
|
|
|
80,300
|
121,000
|
|
|
|
|
|
|
|
Number of share options outstanding in share-based payment arrangement |
|
|
|
|
|
333,500
|
|
333,500
|
516,453
|
|
516,453
|
|
333,500
|
211,300
|
224,300
|
|
516,453
|
|
|
|
|
Change in fair value of derivative, spin-out transaction |
|
|
|
|
|
|
|
|
$ 5,647
|
|
|
|
|
|
|
|
|
|
|
|
|
Revision of Prior Period, Accounting Standards Update, Adjustment [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in fair value of derivatives |
|
|
|
|
|
|
|
$ 656,946
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants issued in public offering [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, exercise price of warrants or rights (in CAD per share) | $ / shares |
|
|
|
$ 6.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, granted, value |
|
|
|
|
|
|
|
|
|
|
|
|
$ 270,400
|
|
|
|
|
|
|
|
|
Class of warrant or right, number of securities called by each warrant or right (in shares) | shares |
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants and rights outstanding, term (Year) |
|
|
|
5 years
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative financial liabilities |
|
|
|
$ 823,597
|
|
$ 656,946
|
|
$ 656,946
|
|
|
|
|
656,946
|
|
|
|
|
|
|
|
|
Total gains (losses) on financial liabilities at fair value through profit or loss |
|
|
|
|
|
|
|
|
|
|
|
|
$ 166,651
|
|
|
|
|
|
|
|
|
Class of warrant or right, granted (in shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
40,000
|
|
|
|
|
|
|
|
|
Underwriter warrants [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, granted (in shares) | shares |
|
|
|
40,000
|
40,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity |
|
|
|
$ 270,400
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants issued in non-brokered private placement [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, exercise price of warrants or rights (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 10
|
|
|
|
|
|
|
|
Class of warrant or right, granted, value |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 22,000
|
|
|
|
|
|
|
|
Class of warrant or right, number of securities called by each warrant or right (in shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
Warrants and rights outstanding, term (Year) |
|
|
|
|
|
|
|
|
|
|
|
|
|
2 years
|
|
|
|
|
|
|
|
Class of warrant or right, granted (in shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
5,765
|
|
|
|
|
|
|
|
Total equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 22,000
|
|
|
|
|
|
|
|
Unit warrants expiring March 13, 2026 [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, exercised during period (in shares) | shares |
|
|
|
|
|
|
|
|
(0)
|
|
|
|
(0)
|
|
|
|
|
|
|
|
|
Class of warrant or right outstanding 1 (in shares) | shares |
|
|
|
|
|
341,592
|
|
341,592
|
341,592
|
[1] |
341,592
|
[1] |
341,592
|
0
|
|
|
341,592
|
[1] |
|
|
|
Unit warrants expiring March 13, 2026 [member] | Major ordinary share transactions [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, exercised during period (in shares) | shares |
|
|
|
|
|
|
334,239
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants expiring November 14, 2026 [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, exercised during period (in shares) | shares |
|
|
|
|
|
|
|
|
(0)
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right outstanding 1 (in shares) | shares |
|
|
|
|
|
0
|
|
0
|
3,045,000
|
[2] |
3,045,000
|
[2] |
0
|
|
|
|
3,045,000
|
[2] |
|
|
|
Warrants expiring November 14, 2026 [member] | Major ordinary share transactions [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, exercised during period (in shares) | shares |
|
|
|
|
|
|
663,700
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unit warrants expiring August 24, 2028 [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, exercised during period (in shares) | shares |
|
|
|
|
|
|
|
|
(0)
|
|
|
|
(0)
|
|
|
|
|
|
|
|
|
Class of warrant or right outstanding 1 (in shares) | shares |
|
|
|
|
|
800,000
|
|
800,000
|
800,000
|
|
800,000
|
|
800,000
|
0
|
|
|
800,000
|
|
|
800,000
|
|
Class of warrants or rights outstanding, value |
|
|
|
|
|
$ 656,946
|
|
$ 656,946
|
$ 152,765
|
|
$ 152,765
|
|
$ 656,946
|
|
|
|
$ 152,765
|
|
|
$ 823,597
|
|
Share purchase warrants expiring August 24, 2028 [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, exercise price of warrants or rights (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 6.25
|
|
|
Class of warrant or right outstanding 1 (in shares) | shares |
[3] |
|
|
|
|
|
|
|
800,000
|
|
800,000
|
|
|
|
|
|
800,000
|
|
|
|
|
Spin-out transaction, payments per warrants exercised (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
$ 0.8114
|
|
|
|
|
|
|
|
|
|
|
|
|
Share purchase warrants expiring July 14, 2028 [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, exercise price of warrants or rights (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
$ 4
|
|
$ 4
|
|
|
|
|
|
$ 4
|
|
|
|
|
Class of warrant or right outstanding 1 (in shares) | shares |
[4] |
|
|
|
|
|
|
|
341,592
|
|
341,592
|
|
|
|
|
|
341,592
|
|
|
|
|
Spin-out transaction, payments per warrants exercised (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
$ 0.3584
|
|
|
|
|
|
|
|
|
|
|
|
|
Share purchase warrants expiring April 29, 2026 [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, exercise price of warrants or rights (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
$ 4
|
|
$ 4
|
|
|
|
|
|
$ 4
|
|
|
|
|
Class of warrant or right outstanding 1 (in shares) | shares |
[5] |
|
|
|
|
|
|
|
247,471
|
|
247,471
|
|
|
|
|
|
247,471
|
|
|
|
|
Spin-out transaction, payments per warrants exercised (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
$ 0.3048
|
|
|
|
|
|
|
|
|
|
|
|
|
Share purchase warrants expiring November 14, 2026 [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, exercise price of warrants or rights (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
$ 4
|
|
$ 4
|
|
|
|
|
|
$ 4
|
|
|
|
|
Class of warrant or right outstanding 1 (in shares) | shares |
[6] |
|
|
|
|
|
|
|
3,045,500
|
|
3,045,500
|
|
|
|
|
|
3,045,500
|
|
|
|
|
Spin-out transaction, payments per warrants exercised (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
$ 0.3584
|
|
|
|
|
|
|
|
|
|
|
|
|
Agent warrants expiring November 14, 2026 [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, exercised during period (in shares) | shares |
|
|
|
|
|
|
|
|
(0)
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right outstanding 1 (in shares) | shares |
|
|
|
|
|
0
|
|
0
|
162,730
|
[7] |
162,730
|
[7] |
0
|
|
|
|
162,730
|
[7] |
|
|
|
Agent warrants expiring November 14, 2026 [member] | Major ordinary share transactions [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, exercised during period (in shares) | shares |
|
|
|
|
|
|
130,184
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agent warrants [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, granted, value |
|
|
|
|
|
|
|
|
$ 201,500
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, granted (in shares) | shares |
|
|
|
|
|
|
|
|
162,781
|
|
|
|
|
|
|
|
|
|
|
|
|
Expense from share-based payment transactions |
|
|
|
|
|
|
|
|
$ 22,001
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, exercised during period (in shares) | shares |
|
|
|
|
|
|
|
|
(0)
|
|
|
|
(0)
|
(0)
|
|
|
|
|
|
|
|
Class of warrant or right outstanding 1 (in shares) | shares |
|
|
|
|
|
49,039
|
|
49,039
|
206,055
|
|
206,055
|
|
49,039
|
5,765
|
0
|
|
206,055
|
|
|
|
|
Number of warrants issued during the period (in shares) | shares |
|
|
|
|
|
|
|
|
5,765
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted share units [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued, settlements of other equity instruments |
|
|
|
|
|
|
|
|
$ 82,570
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based reserves, reallocation to share capital |
|
|
|
|
|
|
|
|
224,591
|
|
|
|
|
|
|
|
|
|
|
|
|
Expense from share-based payment transactions |
|
|
|
|
|
|
|
|
$ 468,247
|
|
|
|
$ 0
|
$ 0
|
|
|
|
|
|
|
|
Number of other equity instruments granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
229,579
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average fair value at measurement date, other equity instruments granted |
|
|
|
|
|
|
|
|
$ 614,957
|
|
$ 614,957
|
|
|
|
|
|
$ 614,957
|
|
|
|
|
Number of other equity instruments vested in share-based payment arrangement |
|
|
|
|
|
|
|
|
79,317
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of other equity instruments exercised or vested in share-based payment arrangement |
|
|
|
|
|
|
|
|
82,570
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted share units [member] | Potential ordinary share transactions [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share options, vesting duration (Year) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 years
|
|
|
|
|
|
Number of other equity instruments vested in share-based payment arrangement |
|
5,362
|
7,088
|
|
|
|
|
|
|
|
|
|
|
|
|
89,674
|
|
|
|
|
|
Common shares [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options exercised in share-based payment arrangement |
|
|
|
|
|
|
|
|
|
|
|
|
36,000
|
13,000
|
|
|
|
|
|
|
|
Proceeds from exercise of options |
|
|
|
|
|
|
|
|
|
|
|
|
$ 131,400
|
$ 77,750
|
|
|
|
|
|
|
|
Increase (decrease) through exercise of options, equity |
|
|
|
|
|
|
|
|
|
|
|
|
$ 53,400
|
78,528
|
|
|
|
|
|
|
|
Exercise price of outstanding share options (in CAD per share) | $ / shares |
|
|
|
|
|
$ 4.95
|
|
$ 4.95
|
|
|
|
|
$ 4.95
|
|
|
|
|
|
|
|
|
Warrants exercised [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from exercise of warrants 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,059,017
|
|
|
|
|
|
|
|
Performance Share Units (PSU) [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of instruments granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
160,000
|
|
|
|
|
Number of share options exercised in share-based payment arrangement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20,000
|
|
|
|
|
Increase (decrease) in number of shares outstanding, share-based payment transactions (in shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
20,000
|
|
|
|
|
|
|
|
Increase (decrease) through share-based payment transactions, equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 355,000
|
|
|
|
|
|
|
|
Share-based arrangement, payment reserve, forfeited |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 723,497
|
|
|
|
|
Number of share options granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
|
|
|
Weighted average exercise price of share options granted in share-based payment arrangement (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 9.1
|
|
|
|
|
Expense from share-based payment transactions |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 363,195
|
|
|
|
|
|
|
|
Number of share options forfeited in share-based payment arrangement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
390,000
|
|
|
|
|
Number of share options outstanding in share-based payment arrangement |
|
|
|
|
|
|
|
|
0
|
|
0
|
|
|
|
250,000
|
|
0
|
|
|
|
|
Share-based arrangement, common shares reserved for issuance (in shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
343,391
|
Share options cancelled under share-based arrangement (in shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
390,000
|
|
|
|
|
|
|
|
Total expense from share-based payment transactions, reversed |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 723,496
|
|
|
|
|
|
|
|
Performance Share Units (PSU) [member] | Company director [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
|
|
|
|
|
40,000
|
|
|
|
|
|
|
|
Expense from share-based payment transactions |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 63,679
|
|
|
|
|
|
|
|
Fair value of share options granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 387,379
|
|
|
|
|
|
|
|
Performance Share Units (PSU) [member] | Company director [member] | Bottom of range [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share options vesting milestone value, per share (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 25
|
|
|
|
|
|
|
|
Performance Share Units (PSU) [member] | Company director [member] | Top of range [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share options vesting milestone value, per share (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 87.5
|
|
|
|
|
|
|
|
Performance Share Units (PSU) [member] | Company directors [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
|
|
|
|
|
120,000
|
|
|
|
|
|
|
|
Expense from share-based payment transactions |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 55,615
|
|
|
|
|
|
|
|
Fair value of share options granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,246,463
|
|
|
|
|
|
|
|
Performance Share Units (PSU) [member] | Company directors [member] | Bottom of range [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share options vesting milestone value, per share (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 19.5
|
|
|
|
|
|
|
|
Performance Share Units (PSU) [member] | Company directors [member] | Top of range [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share options vesting milestone value, per share (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 68
|
|
|
|
|
|
|
|
Performance Share Units (PSU) [member] | Other related parties [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase (decrease) through share-based payment transactions, equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 355,000
|
|
|
|
|
|
|
|
The 2023 stock incentive plan [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based compensation, number of shares authorized (in shares) | shares |
|
|
|
|
|
|
|
|
1,500,000
|
|
1,500,000
|
|
|
|
|
|
1,500,000
|
|
|
|
|
Options issued to consultant one [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
36,000
|
|
|
|
17,500
|
20,000
|
|
|
|
|
|
|
|
Weighted average exercise price of share options granted in share-based payment arrangement (in CAD per share) | (per share) |
|
|
|
|
|
|
|
|
$ 3.91
|
|
$ 2.84
|
|
$ 5.65
|
$ 12.75
|
|
|
|
|
|
|
|
Share-based payment arrangement, options, fair value |
|
|
|
|
|
$ 60,200
|
|
$ 60,200
|
$ 112,200
|
|
$ 112,200
|
|
$ 60,200
|
$ 198,300
|
|
|
$ 112,200
|
|
|
|
|
Share-based payment arrangement, award vesting period (Year) |
|
|
|
|
|
|
|
|
|
|
|
|
3 years
|
3 years
|
|
|
|
|
|
|
|
Options issued to directors and officers [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
83,194
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average exercise price of share options granted in share-based payment arrangement (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
$ 2.76
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based payment arrangement, options, fair value |
|
|
|
|
|
|
|
|
$ 167,600
|
|
$ 167,600
|
|
|
|
|
|
$ 167,600
|
|
|
|
|
Number of share options vested under share-based arrangements (in shares) | shares |
|
|
|
|
|
|
|
|
51,323
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of unvested stock options outstanding (in shares) | shares |
|
|
|
|
|
|
|
|
31,871
|
|
31,871
|
|
|
|
|
|
31,871
|
|
|
|
|
Share options, vesting duration (Year) |
|
|
|
|
|
|
|
|
3 years
|
|
|
|
|
|
|
|
|
|
|
|
|
Expense from share-based payment transactions |
|
|
|
|
|
|
|
|
$ 133,795
|
|
|
|
|
|
|
|
|
|
|
|
|
Options issued to consultant two [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
55,000
|
|
|
|
|
8,000
|
|
|
|
|
|
|
|
Weighted average exercise price of share options granted in share-based payment arrangement (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
$ 2.76
|
|
|
|
|
$ 13.75
|
|
|
|
|
|
|
|
Share-based payment arrangement, options, fair value |
|
|
|
|
|
|
|
|
$ 91,100
|
|
$ 91,100
|
|
|
$ 83,200
|
|
|
$ 91,100
|
|
|
|
|
Share-based payment arrangement, award vesting period (Year) |
|
|
|
|
|
|
|
|
|
|
|
|
|
3 years
|
|
|
|
|
|
|
|
Options issued to a director, officer, and consultant [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
36,815
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average exercise price of share options granted in share-based payment arrangement (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
$ 2.76
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based payment arrangement, options, fair value |
|
|
|
|
|
|
|
|
$ 77,400
|
|
$ 77,400
|
|
|
|
|
|
77,400
|
|
|
|
|
Options issued to consultant three [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
36,000
|
|
|
|
20,000
|
62,000
|
|
|
|
|
|
|
|
Weighted average exercise price of share options granted in share-based payment arrangement (in CAD per share) | (per share) |
|
|
|
|
|
|
|
|
$ 1.38
|
|
$ 0.99
|
|
$ 3.3
|
$ 9
|
|
|
|
|
|
|
|
Share-based payment arrangement, options, fair value |
|
|
|
|
|
36,000
|
|
36,000
|
$ 39,900
|
|
$ 39,900
|
|
$ 36,000
|
$ 395,600
|
|
|
39,900
|
|
|
|
|
Share-based payment arrangement, award vesting period (Year) |
|
|
|
|
|
|
|
|
|
|
|
|
2 years
|
3 years
|
|
|
|
|
|
|
|
Options issued to director [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
9,200
|
|
|
|
20,000
|
|
|
|
|
|
|
|
|
Weighted average exercise price of share options granted in share-based payment arrangement (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
$ 1.38
|
|
|
|
$ 5.47
|
|
|
|
|
|
|
|
|
Share-based payment arrangement, options, fair value |
|
|
|
|
|
75,500
|
|
75,500
|
$ 10,200
|
|
10,200
|
|
$ 75,500
|
|
|
|
10,200
|
|
|
|
|
Share-based payment arrangement, award vesting period (Year) |
|
|
|
|
|
|
|
|
|
|
|
|
3 years
|
|
|
|
|
|
|
|
|
options issued to consultant four [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
83,333
|
|
|
|
36,000
|
31,000
|
|
|
|
|
|
|
|
Weighted average exercise price of share options granted in share-based payment arrangement (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
$ 1.2
|
|
|
|
$ 3.65
|
$ 9.5
|
|
|
|
|
|
|
|
Share-based payment arrangement, options, fair value |
|
|
|
|
|
53,400
|
|
53,400
|
$ 61,800
|
|
$ 61,800
|
|
$ 53,400
|
$ 208,600
|
|
|
$ 61,800
|
|
|
|
|
Share-based payment arrangement, award vesting period (Year) |
|
|
|
|
|
|
|
|
|
|
|
|
1 year
|
2 years
|
|
|
|
|
|
|
|
Options issued to directors and a consultant [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
|
|
|
|
40,000
|
|
|
|
|
|
|
|
|
Weighted average exercise price of share options granted in share-based payment arrangement (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
$ 6.6
|
|
|
|
|
|
|
|
|
Share-based payment arrangement, options, fair value |
|
|
|
|
|
173,500
|
|
173,500
|
|
|
|
|
$ 173,500
|
|
|
|
|
|
|
|
|
Share-based payment arrangement, award vesting period (Year) |
|
|
|
|
|
|
|
|
|
|
|
|
3 years
|
|
|
|
|
|
|
|
|
Options issued to officers [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
|
|
|
|
85,000
|
|
|
|
|
|
|
|
|
Weighted average exercise price of share options granted in share-based payment arrangement (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
$ 6.6
|
|
|
|
|
|
|
|
|
Share-based payment arrangement, options, fair value |
|
|
|
|
|
445,500
|
|
445,500
|
|
|
|
|
$ 445,500
|
|
|
|
|
|
|
|
|
Share-based payment arrangement, award vesting period (Year) |
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
Options issued to officer [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
|
|
|
|
20,000
|
|
|
|
|
|
|
|
|
Weighted average exercise price of share options granted in share-based payment arrangement (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
$ 3.98
|
|
|
|
|
|
|
|
|
Share-based payment arrangement, options, fair value |
|
|
|
|
|
$ 66,600
|
|
$ 66,600
|
|
|
|
|
$ 66,600
|
|
|
|
|
|
|
|
|
Share-based payment arrangement, award vesting period (Year) |
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
Consultant options [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of outstanding share options (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
$ 4.95
|
|
$ 4.95
|
|
|
|
|
|
$ 4.95
|
|
|
|
|
Share-based arrangement, payment reserve, forfeited |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 891,400
|
|
|
|
|
|
|
|
Number of share options forfeited in share-based payment arrangement |
|
|
|
|
|
|
|
|
|
|
|
|
|
121,000
|
|
|
|
|
|
|
|
Stock options expiring April 1, 2029 [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options exercised in share-based payment arrangement |
|
|
|
|
|
|
|
|
(0)
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
83,194
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options forfeited in share-based payment arrangement |
|
|
|
|
|
|
|
|
11,589
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options outstanding in share-based payment arrangement |
|
|
|
|
|
0
|
|
0
|
71,605
|
[8] |
71,605
|
[8] |
0
|
|
|
|
71,605
|
[8] |
|
|
|
Stock options expiring April 1, 2029 [member] | Major ordinary share transactions [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options exercised in share-based payment arrangement |
|
|
|
|
|
|
10,623
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options expiring November 15, 2027 [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options exercised in share-based payment arrangement |
|
|
|
|
|
|
|
|
(0)
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
55,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options forfeited in share-based payment arrangement |
|
|
|
|
|
|
|
|
(0)
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options outstanding in share-based payment arrangement |
|
|
|
|
|
0
|
|
0
|
55,000
|
[9] |
55,000
|
[9] |
0
|
|
|
|
55,000
|
[9] |
|
|
|
Stock options expiring November 15, 2027 [member] | Major ordinary share transactions [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options exercised in share-based payment arrangement |
|
|
|
|
|
|
37,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options expiring November 15, 2029 [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options exercised in share-based payment arrangement |
|
|
|
|
|
|
|
|
(0)
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
36,815
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options forfeited in share-based payment arrangement |
|
|
|
|
|
|
|
|
(0)
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options outstanding in share-based payment arrangement |
|
|
|
|
|
0
|
|
0
|
36,815
|
[10] |
36,815
|
[10] |
0
|
|
|
|
36,815
|
[10] |
|
|
|
Stock options expiring November 15, 2029 [member] | Major ordinary share transactions [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options exercised in share-based payment arrangement |
|
|
|
|
|
|
20,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options expiring February 12, 2030 [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options exercised in share-based payment arrangement |
|
|
|
|
|
|
|
|
(0)
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
36,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options forfeited in share-based payment arrangement |
|
|
|
|
|
|
|
|
(0)
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options outstanding in share-based payment arrangement |
|
|
|
|
|
0
|
|
0
|
36,000
|
[11] |
36,000
|
[11] |
0
|
|
|
|
36,000
|
[11] |
|
|
|
Stock options expiring February 12, 2030 [member] | Major ordinary share transactions [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options exercised in share-based payment arrangement |
|
|
|
|
|
|
10,319
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options exercised in share-based payment arrangement |
|
|
|
|
|
|
|
|
36,000
|
|
|
|
|
13,000
|
|
|
|
|
|
|
|
Increase (decrease) through exercise of options, equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 78,528
|
|
|
|
|
|
|
|
Options issued to consultant seven [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
Performance stock options [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options expired in share-based payment arrangement |
|
|
|
|
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
Number of share options granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average exercise price of share options granted in share-based payment arrangement (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 14.25
|
|
|
|
|
|
|
Expense from share-based payment transactions |
|
|
|
|
|
|
|
|
$ 0
|
|
|
|
$ 0
|
$ 63,148
|
|
|
|
|
|
|
|
Share-based payment arrangement, award vesting period (Year) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 years
|
|
|
|
|
|
|
Fair value of share options granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 126,297
|
|
|
|
|
|
|
Share-based payment arrangement, award vesting percentage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.00%
|
|
|
|
|
|
|
Number of share options outstanding in share-based payment arrangement |
|
|
|
|
|
|
|
|
0
|
|
0
|
|
|
|
|
|
0
|
|
|
|
|
Performance Share Units (PSU) modified from earlier grants [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of share options granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
|
|
|
|
|
140,000
|
|
|
|
|
|
|
|
Expense from share-based payment transactions |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 64,884
|
|
|
|
|
|
|
|
Fair value of share options granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,068,398
|
|
|
|
|
|
|
|
Performance Share Units (PSU) modified from earlier grants [member] | Bottom of range [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share options vesting milestone value, per share (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 19.5
|
|
|
|
|
|
|
|
Performance Share Units (PSU) modified from earlier grants [member] | Top of range [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share options vesting milestone value, per share (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 68
|
|
|
|
|
|
|
|
Restricted share units vesting on April 25, 2025 or on resignation [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of other equity instruments vested in share-based payment arrangement |
|
|
|
|
|
|
|
|
48,138
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted share units vesting on April 25, 2025 or on resignation [member] | Potential ordinary share transactions [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of other equity instruments vested in share-based payment arrangement |
|
|
40,276
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted share units vesting on resignation [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of other equity instruments vested in share-based payment arrangement |
|
|
|
|
|
|
|
|
7,862
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted share units granted in November 15, 2024 [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of other equity instruments granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
222,491
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of other equity instruments exercised or vested in share-based payment arrangement |
|
|
|
|
|
|
|
|
82,570
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted share units granted in November 15, 2024 [member] | Major ordinary share transactions [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of other equity instruments exercised or vested in share-based payment arrangement |
|
|
|
|
|
|
51,193
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Peg North property [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase (decrease) in number of shares outstanding, exploration and evaluation assets option agreement (in shares) | shares |
|
|
|
|
|
|
|
|
28,818
|
|
|
|
13,072
|
10,526
|
|
|
|
|
|
|
|
Increase (decrease) in equity, evaluation and exploration assets option agreement |
|
|
|
|
|
|
|
|
$ 100,000
|
|
|
|
$ 100,000
|
$ 100,000
|
|
|
|
|
|
|
|
Jean lake property [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase (decrease) in number of shares outstanding, exploration and evaluation assets option agreement (in shares) | shares |
|
|
|
|
|
|
|
|
12,106
|
|
|
|
6,128
|
6,705
|
|
|
|
|
|
|
|
Increase (decrease) in equity, evaluation and exploration assets option agreement |
|
|
|
|
|
|
|
|
$ 50,000
|
|
|
|
$ 50,000
|
$ 50,000
|
|
|
|
|
|
|
|
Athabasca properties [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase (decrease) in number of shares outstanding, exploration and evaluation assets option agreement (in shares) | shares |
|
|
|
|
|
|
|
|
1,795,492
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase (decrease) in equity, evaluation and exploration assets option agreement |
|
|
|
|
|
|
|
|
$ 6,716,449
|
|
|
|
|
|
|
|
|
|
|
|
|
Lac Simard South property [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase (decrease) in number of shares outstanding, exploration and evaluation assets option agreement (in shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
10,700
|
|
|
|
|
|
|
|
|
Increase (decrease) in equity, evaluation and exploration assets option agreement |
|
|
|
|
|
|
|
|
|
|
|
|
$ 85,600
|
|
|
|
|
|
|
|
|
Jol Lithium property [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase (decrease) in number of shares outstanding, exploration and evaluation assets option agreement (in shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
364
|
|
|
|
|
|
|
|
Increase (decrease) in equity, evaluation and exploration assets option agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,454
|
|
|
|
|
|
|
|
Flow-through shares issued in private placement [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuing other equity instruments |
|
|
|
|
|
|
|
|
7,536,379
|
|
|
|
|
|
|
|
|
|
|
|
|
Commitment to incur expenses |
|
|
|
|
|
|
|
|
7,191,300
|
|
$ 7,191,300
|
|
|
|
|
|
$ 7,191,300
|
|
|
|
|
Finders warrants [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Flow-through premium liability |
|
|
|
|
|
$ 20,143
|
|
$ 20,143
|
|
|
|
|
20,143
|
|
|
|
|
|
|
|
|
Commitment to incur expenses |
|
|
|
|
|
1,109,268
|
|
1,109,268
|
|
|
|
|
1,109,268
|
|
|
|
|
|
|
|
|
Warrant premium |
|
|
|
|
|
377,911
|
|
$ 377,911
|
|
|
|
|
377,911
|
|
|
|
|
|
|
|
|
Tranche 2 of private placement [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Flow-through premium liability |
|
|
|
|
|
|
|
|
537,012
|
|
537,012
|
|
|
|
|
|
537,012
|
|
|
|
|
Cash finder's fees paid |
|
|
|
|
|
|
|
|
175
|
|
|
|
|
|
|
|
|
|
|
|
|
Legal and filing fees |
|
|
|
|
|
|
|
|
22,694
|
|
|
|
|
|
|
|
|
|
|
|
|
Commitment to incur expenses |
|
|
|
|
|
|
|
|
1,455,129
|
|
$ 1,455,129
|
|
|
|
|
|
$ 1,455,129
|
|
|
|
|
Qualifying CEE |
|
|
|
|
|
|
|
|
$ 327,605
|
|
|
|
|
|
|
|
|
|
|
|
|
Tranche 2 of private placement [member] | Flow-through shares issued in private placement [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of instruments granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
247,471
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, exercise price of warrants or rights (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
$ 5.88
|
|
$ 5.88
|
|
|
|
|
|
$ 5.88
|
|
|
|
|
Proceeds from issuing other equity instruments |
|
|
|
|
|
|
|
|
$ 1,455,129
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from exercise of warrants |
|
|
|
|
|
$ 105,000
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
|
Tranche 2 of private placement [member] | Warrants issued in non-brokered private placement [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, exercise price of warrants or rights (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
$ 4
|
|
4
|
|
|
|
|
|
4
|
|
|
|
|
Weighted average trading price (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
6
|
|
6
|
|
|
|
|
|
6
|
|
|
|
|
Tranche 2 of private placement [member] | Finders warrants [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, exercise price of warrants or rights (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
$ 3.4
|
|
$ 3.4
|
|
|
|
|
|
$ 3.4
|
|
|
|
|
Increase (decrease) in number of shares outstanding, shares issued, share purchase finders warrants (in shares) | shares |
|
|
|
|
|
|
|
|
51
|
|
51
|
|
|
|
|
|
51
|
|
|
|
|
Class of warrant or right, granted, value |
|
|
|
|
|
|
|
|
$ 100
|
|
|
|
|
|
|
|
|
|
|
|
|
Second nonbrokered private placement [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of instruments granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
1,473,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, exercise price of warrants or rights (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
$ 3
|
|
$ 3
|
|
|
|
|
|
$ 3
|
|
|
|
|
Proceeds from issuing other equity instruments |
|
|
|
|
|
|
|
|
$ 4,419,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from exercise of warrants |
|
|
|
|
|
|
|
|
$ 368,250
|
|
|
|
|
|
|
|
|
|
|
|
|
Second nonbrokered private placement [member] | Warrants issued in non-brokered private placement [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, exercise price of warrants or rights (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
$ 4
|
|
4
|
|
|
|
|
|
4
|
|
|
|
|
Second nonbrokered private placement [member] | Finders warrants [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of instruments granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
162,730
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, exercise price of warrants or rights (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
$ 3
|
|
$ 3
|
|
|
|
|
|
$ 3
|
|
|
|
|
Proceeds from issuing other equity instruments |
|
|
|
|
|
|
|
|
$ 201,400
|
|
|
|
|
|
|
|
|
|
|
|
|
Finders fee |
|
|
|
|
|
|
|
|
570,015
|
|
$ 570,015
|
|
|
|
|
|
$ 570,015
|
|
|
|
|
Payments for share issue costs |
|
|
|
|
|
|
|
|
$ 82,673
|
|
|
|
|
|
|
|
|
|
|
|
|
Tranche 2 of second private placement [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of instruments granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
1,022,500
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, exercise price of warrants or rights (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
$ 3.5
|
|
$ 3.5
|
|
|
|
|
|
$ 3.5
|
|
|
|
|
Proceeds from issuing other equity instruments |
|
|
|
|
|
|
|
|
$ 3,578,750
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from exercise of warrants |
|
|
|
|
|
|
|
|
255,625
|
|
|
|
|
|
|
|
|
|
|
|
|
Flow-through premium liability |
|
|
|
|
|
|
|
|
511,250
|
|
$ 511,250
|
|
|
|
|
|
$ 511,250
|
|
|
|
|
Commitment to incur expenses |
|
|
|
|
|
|
|
|
3,578,750
|
|
$ 3,578,750
|
|
|
|
|
|
$ 3,578,750
|
|
|
|
|
Qualifying CEE |
|
|
|
|
|
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
|
Tranche 2 of second private placement [member] | Warrants issued in non-brokered private placement [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, exercise price of warrants or rights (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
$ 4
|
|
$ 4
|
|
|
|
|
|
$ 4
|
|
|
|
|
Tranche 3 of second private placement [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of instruments granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
550,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, exercise price of warrants or rights (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
$ 4.55
|
|
$ 4.55
|
|
|
|
|
|
$ 4.55
|
|
|
|
|
Proceeds from issuing other equity instruments |
|
|
|
|
|
|
|
|
$ 2,502,500
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from exercise of warrants |
|
|
|
|
|
|
|
|
137,500
|
|
|
|
|
|
|
|
|
|
|
|
|
Flow-through premium liability |
|
|
|
|
|
|
|
|
852,500
|
|
$ 852,500
|
|
|
|
|
|
$ 852,500
|
|
|
|
|
Commitment to incur expenses |
|
|
|
|
|
|
|
|
2,502,500
|
|
$ 2,502,500
|
|
|
|
|
|
$ 2,502,500
|
|
|
|
|
Qualifying CEE |
|
|
|
|
|
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
|
Tranche 3 of second private placement [member] | Warrants issued in non-brokered private placement [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, exercise price of warrants or rights (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
$ 4
|
|
$ 4
|
|
|
|
|
|
$ 4
|
|
|
|
|
Shares issued in public offering [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments for share issue costs |
|
|
|
$ 387,416
|
$ 286,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total increase (decrease) in number of shares outstanding (in shares) | shares |
|
|
|
800,000
|
800,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants per unit (in shares) | shares |
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of common shares per unit (in shares) | shares |
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued, price per share (in CAD per share) | (per share) |
|
|
|
$ 6.77
|
$ 5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuing shares |
|
|
|
$ 5,418,400
|
$ 4,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tranche 1 of private placement [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash finder's fees paid |
|
|
|
|
|
|
|
|
|
|
|
|
$ 11,134
|
|
|
|
|
|
|
|
|
Tranche 1 of private placement [member] | Flow-through shares issued in private placement [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of instruments granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
|
|
|
|
188,651
|
|
|
|
|
|
|
|
|
Class of warrant or right, exercise price of warrants or rights (in CAD per share) | $ / shares |
|
|
|
|
|
$ 5.88
|
|
$ 5.88
|
|
|
|
|
$ 5.88
|
|
|
|
|
|
|
|
|
Proceeds from issuing other equity instruments |
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,109,268
|
|
|
|
|
|
|
|
|
Proceeds from exercise of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,109,268
|
|
|
|
|
|
|
|
|
Tranche 1 of private placement [member] | Warrants issued in non-brokered private placement [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, exercise price of warrants or rights (in CAD per share) | $ / shares |
|
|
|
|
|
4
|
|
4
|
|
|
|
|
$ 4
|
|
|
|
|
|
|
|
|
Weighted average trading price (in CAD per share) | $ / shares |
|
|
|
|
|
6
|
|
6
|
|
|
|
|
6
|
|
|
|
|
|
|
|
|
Tranche 1 of private placement [member] | Finders warrants [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right, exercise price of warrants or rights (in CAD per share) | $ / shares |
|
|
|
|
|
$ 3.4
|
|
$ 3.4
|
|
|
|
|
$ 3.4
|
|
|
|
|
|
|
|
|
Increase (decrease) in number of shares outstanding, shares issued, share purchase finders warrants (in shares) | shares |
|
|
|
|
|
3,274
|
|
3,274
|
|
|
|
|
3,274
|
|
|
|
|
|
|
|
|
Class of warrant or right, granted, value |
|
|
|
|
|
|
|
|
|
|
|
|
$ 9,700
|
|
|
|
|
|
|
|
|
Qualifying CEE |
|
|
|
|
|
|
|
|
$ 1,109,268
|
|
|
|
|
|
|
|
|
|
|
|
|
Tranche 1 of private placement [member] | Non-flow-through units issued in private placement [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of instruments granted in share-based payment arrangement |
|
|
|
|
|
|
|
|
|
|
|
|
152,941
|
|
|
|
|
|
|
|
|
Class of warrant or right, exercise price of warrants or rights (in CAD per share) | $ / shares |
|
|
|
|
|
$ 3.4
|
|
$ 3.4
|
|
|
|
|
$ 3.4
|
|
|
|
|
|
|
|
|
Proceeds from exercise of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
$ 520,000
|
|
|
|
|
|
|
|
|
Shares issued in non-brokered private placement [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Flow-through premium liability |
|
|
|
|
|
|
|
|
|
|
|
|
|
977,534
|
|
|
|
|
|
|
|
Payments for share issue costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 99,624
|
|
|
|
|
|
|
|
Shares issued, price per share (in CAD per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 17
|
|
|
|
|
|
|
|
Proceeds from issuing shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,661,807
|
|
|
|
|
|
|
|
Increase (decrease) in number of shares outstanding, private placement (in shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
97,753
|
|
|
|
|
|
|
|
|
|